WO2005021724A3 - Gp115: methodes et compositions permettant de traiter le cancer - Google Patents

Gp115: methodes et compositions permettant de traiter le cancer Download PDF

Info

Publication number
WO2005021724A3
WO2005021724A3 PCT/US2004/027968 US2004027968W WO2005021724A3 WO 2005021724 A3 WO2005021724 A3 WO 2005021724A3 US 2004027968 W US2004027968 W US 2004027968W WO 2005021724 A3 WO2005021724 A3 WO 2005021724A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating cancer
compositions
methods
gene
disclosed
Prior art date
Application number
PCT/US2004/027968
Other languages
English (en)
Other versions
WO2005021724A2 (fr
Inventor
Ronan C O'hagan
Karuppiah Kannan
David Bailey
Original Assignee
Genpath Pharmaceuticals Inc
Ronan C O'hagan
Karuppiah Kannan
David Bailey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genpath Pharmaceuticals Inc, Ronan C O'hagan, Karuppiah Kannan, David Bailey filed Critical Genpath Pharmaceuticals Inc
Publication of WO2005021724A2 publication Critical patent/WO2005021724A2/fr
Publication of WO2005021724A3 publication Critical patent/WO2005021724A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation de molécules concernant le gène GP115 (C17orf26) pour traiter le cancer et d'autres états hyperprolifératifs. L'invention concerne également des mammifères non humains hébergeant une modification génétique concernant le gène GP115 et leur utilisation comme modèles expérimentaux du cancer.
PCT/US2004/027968 2003-08-27 2004-08-27 Gp115: methodes et compositions permettant de traiter le cancer WO2005021724A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49839303P 2003-08-27 2003-08-27
US60/498,393 2003-08-27

Publications (2)

Publication Number Publication Date
WO2005021724A2 WO2005021724A2 (fr) 2005-03-10
WO2005021724A3 true WO2005021724A3 (fr) 2005-05-12

Family

ID=34272666

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/027968 WO2005021724A2 (fr) 2003-08-27 2004-08-27 Gp115: methodes et compositions permettant de traiter le cancer

Country Status (1)

Country Link
WO (1) WO2005021724A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112394168B (zh) * 2019-08-15 2023-02-14 中山大学附属第六医院 IgA2检测试剂在制备KRAS突变型结直肠癌诊断剂方面的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012662A2 (fr) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Proteines associees a la membrane
WO2003039443A2 (fr) * 2001-11-05 2003-05-15 Deutsches Krebsforschungszentrum Nouveaux marqueurs genetiques pour leucemies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012662A2 (fr) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Proteines associees a la membrane
WO2003039443A2 (fr) * 2001-11-05 2003-05-15 Deutsches Krebsforschungszentrum Nouveaux marqueurs genetiques pour leucemies

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAGHERI-FAM STEFAN ET AL: "Comparative genomics of the SOX9 region in human and Fugu rubripes: Conservation of short regulatory sequence elements within large intergenic regions", GENOMICS, vol. 78, no. 1-2, November 2001 (2001-11-01), pages 73 - 82, XP002312982, ISSN: 0888-7543 *
FRASER A G ET AL: "Functional genomic analysis of C. Elegans chromosome I by systematic RNA interference", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 408, 16 November 2000 (2000-11-16), pages 325 - 330, XP002953443, ISSN: 0028-0836 *
MCMANUS M T ET AL: "Gene silencing in mammals by small interfering RNAs", NATURE REVIEWS GENETICS, MACMILLAN MAGAZINES, GB, vol. 3, October 2002 (2002-10-01), pages 737 - 747, XP002973403 *
WALHOUT ALBERTHA J M ET AL: "Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline.", CURRENT BIOLOGY : CB. 19 NOV 2002, vol. 12, no. 22, 19 November 2002 (2002-11-19), pages 1952 - 1958, XP002312983, ISSN: 0960-9822 *

Also Published As

Publication number Publication date
WO2005021724A2 (fr) 2005-03-10

Similar Documents

Publication Publication Date Title
WO2006073839A3 (fr) Proteases antifongiques acides
WO2004013280A3 (fr) Silençage genique a mediation par arnsi specifique des alleles
WO2003102214A3 (fr) Procede d'interference efficace par arn dans des cellules de mammifere
WO2007031877A3 (fr) Modulation de proprietes immunostimulantes de petits arn interferents (petits arni) par modification de nucleotides
AU2003202585A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
AU2003297474A1 (en) Methods of inhibiting gene expression by rna interference
WO2004013310A3 (fr) Methodes de diminution d'expression de gene cible in vivo par introduction d'arn interferant
WO2005059097A3 (fr) Procedes de production a fidelite elevee de longues molecules d'acide nucleique
AU2003258452A1 (en) Rna interference based methods and compositions for inhibiting hbv gene expression
AU2003243541A1 (en) Methods and compositions relating to labeled rna molecules that reduce gene expression
AU2003213054A1 (en) RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2004063185A8 (fr) Thiophene carboxamides utilises en tant qu'inhibiteurs de l'enzyme ikk-2
WO2005001039A3 (fr) Production de petits arn interferents (arnsi) regulee par les ribozymes et procedes d'utilisation de ceux-ci
WO2006066153A8 (fr) Chromoproteine d'actinomadura, apoproteine et groupe de genes
AU2003233717A1 (en) Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
WO2002059322A3 (fr) Compositions et methodes liees a la famille de genes biosynthetiques de la daptomycine
WO2003014297A3 (fr) Compositions et procedes relatifs a la famille multigenique biosynthetique de la daptomycine
WO2005014607A3 (fr) Modulation antisens de l'expression de la stearoyl-coa desaturase
WO2005021724A3 (fr) Gp115: methodes et compositions permettant de traiter le cancer
AU2003238899A1 (en) Method of controling acetylation of metabolic enzymes
WO2005001031A3 (fr) Modulation de la voie d'interference arn
WO2006053125A3 (fr) Gp201: procedes et compositions de traitement du cancer
WO2004072023A3 (fr) Oxathiine-carboxamides
WO2005042480A3 (fr) Pyrazolylcarboxanilides n-substitues
WO2005012275A3 (fr) Composes benzo[1,2,5]thiadiazole

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase